The 20 Best Mesothelioma Doctors Near Me in Berkeley, CA

David Jablons is a Thoracic Surgeon practicing medicine in San Francisco, California. Dr. Jablons is rated as an Elite provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymectomy, and Endoscopy.

Oleg Krijanovski is a Hematologist practicing medicine in Berkeley, California. Dr. Krijanovski is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is board certified in Hematology - Board Certified and Medical Oncology - Board Certified. Dr. Krijanovski is currently accepting new patients.

Uma Suryadevara is a Hematologist practicing medicine in Berkeley, California. Dr. Suryadevara is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Bone Marrow Aspiration. Dr. Suryadevara is board certified in Hematology - Board Certified and Medical Oncology - Board Certified. Dr. Suryadevara is currently accepting new patients.

Thierry Jahan is an Oncologist practicing medicine in San Francisco, California. Dr. Jahan is rated as an Elite provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Epithelioid Sarcoma, Adult Soft Tissue Sarcoma, and Lung Cancer.

Wendy Patton is a Radiologist practicing medicine in Oakland, California. Dr. Patton is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Scrotal Swelling, Aseptic and Alopecic Nodules of Scalp (AANS), Progressive Familial Intrahepatic Cholestasis Type 2, and Progressive Familial Intrahepatic Cholestasis Type 1.

Liina Poder is a Radiologist practicing medicine in San Francisco, California. Dr. Poder is rated as an Advanced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Jaundice, Visceromegaly, WT1-Related Wilms Tumor Syndromes, and Placenta Previa. Dr. Poder is board certified in American Board Of Radiology, Diagnostic Radiology. Dr. Poder is currently accepting new patients.

Dr. Sophia Rahman is a radiation oncologist who cares for patients with cancer. She is especially focused on caring for patients with breast cancer, lung cancer, or head and neck cancer. Rahman earned her medical degree from the David Geffen School of Medicine at the University of California, Los Angeles. She completed residencies in internal medicine and radiation oncology at Kaiser Permanente. Dr. Rahman is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Intraductal Papilloma, Nasopharyngeal Carcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Gamma Knife Radiosurgery. Dr. Rahman is board certified in American Board Of Radiology, Radiation Oncology. Dr. Rahman is currently accepting new patients.

Dr. Derek Sun is a radiologist who interprets medical imaging that includes X-rays, ultrasound images, CT scans and MRI. He has a particular interest in diseases and conditions of the abdomen and pelvis. Sun earned his medical degree at Albert Einstein College of Medicine. He completed a residency in radiology at NYC Health + Hospitals/Jacobi, followed by a fellowship in abdominal imaging at UCSF. Sun is passionate about educating physicians-in-training. He serves as associate director of UCSF’s program in abdominal imaging and ultrasound, for which he teaches high-level concepts in medical imaging. He received the Hideyo Minagi Outstanding Teacher Award in 2019. A native San Franciscan, Sun enjoys giving back to his community. He volunteers at a local food bank and promotes STEM education (science, technology, engineering and mathematics) to Bay Area students. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Chronic Cough, Fibrolamellar Carcinoma, WT1-Related Wilms Tumor Syndromes, Progressive Familial Intrahepatic Cholestasis Type 1, and Small Bowel Resection. Dr. Sun is board certified in American Board Of Radiology, Diagnostic Radiology. Dr. Sun is currently accepting new patients.

Dr. Spencer Behr is a radiologist with expertise in molecular imaging, radiation therapy and abdominal imaging. He has a special interest in radiomics, extracting data from medical images that can be used to better predict and assess a patient's response to cancer treatment. Behr pursues translational research – applying laboratory findings to the development of medical therapies – on the use of molecular and hybrid imaging to better treat prostate cancer. He is particularly interested in new radiology techniques that combine PET scanning with CT or MRI. He has pursued research projects that involve collaboration among multiple departments, aiming to foster discussions among specialists of various disciplines and to optimize the impact of these studies on patient care. Behr earned his medical degree from Tufts University School of Medicine. He completed a residency in diagnostic radiology at Lahey Hospital & Medical Center, serving as chief resident. At UCSF, he completed fellowships in abdominal imaging and nuclear medicine. Behr enjoys mentoring medical students, residents and fellows, and has received national recognition for his excellence in teaching and mentoring. He serves as fellowship director for radiology and biomedical imaging, co-director of the Helen Diller Family Comprehensive Cancer Center's Cancer Imaging Research Shared Resource and vice chair of UCSF's Committee on Rules & Jurisdiction. Dr. Behr is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Ureterocele, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Prostatectomy. Dr. Behr is board certified in American Board Of Nuclear Medicine, Nuclear Medicine and American Board Of Radiology, Diagnostic Radiology.

Dr. Robert Flavell is a radiologist who cares for both adults and children, and specializes in nuclear medicine, the use of small amounts of radioactive materials to evaluate organ systems. He is chief of molecular imaging and therapeutics for the UCSF Department of Radiology and Biomedical Imaging. In research, Flavell focuses on developing new methods of diagnosing and treating cancer using molecular imaging technology, which shows what is taking place in the body at a cellular and molecular level. After earning a doctorate in chemical biology at the Rockefeller University, Flavell earned his medical degree at Weill Cornell Medicine. At UCSF, he completed a residency in diagnostic radiology, followed by a fellowship in nuclear medicine. Dr. Flavell is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Smoldering Multiple Myeloma, Fibrolamellar Carcinoma, and Gastrointestinal Stromal Tumor. Dr. Flavell is board certified in American Board Of Radiology, Diagnostic Radiology and American Board Of Nuclear Medicine, Nuclear Medicine. Dr. Flavell is currently accepting new patients.

Dr. Benjamin M. Yeh is a radiologist who specializes in abdominal imaging. He has particular expertise in computed tomography (CT), contrast materials (substances introduced to make certain internal structures more visible), advanced liver imaging, and imaging of the genital and urinary organs. Yeh has received grants from the National Institutes of Health to study and develop novel CT contrast materials. He holds three patents. Yeh earned his medical degree at Duke University. He completed a residency in radiology and a fellowship in abdominal imaging at UCSF. Yeh is active in teaching at UCSF. Dr. Yeh is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, WT1-Related Wilms Tumor Syndromes, Small Bowel Resection, and Liver Embolization. Dr. Yeh is board certified in American Board Of Radiology, Diagnostic Radiology.

Marie Pierre is a primary care provider, practicing in Internal Medicine in Oakland, California. Dr. Pierre is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. Her clinical expertise encompasses Familial Neurocardiogenic Syncope, Fainting, Inappropriate Sinus Tachycardia (IST), and Sickle Cell Disease.

Li Xiao is a primary care provider, practicing in Family Medicine in Oakland, California. Dr. Xiao is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Mycoplasma Pneumonia, Atypical Pneumonia, Lemierre Syndrome, and Urethritis.

Jeffrey Velotta is a General Surgeon and a Thoracic Surgeon practicing medicine in Oakland, California. Dr. Velotta is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Thymic Epithelial Tumor, Congenital Unilateral Pulmonary Hypoplasia, Thymectomy, and Endoscopy. Dr. Velotta is currently accepting new patients.

Xingyue Wang is a primary care provider, practicing in Family Medicine in Oakland, California. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Lung Transplant.

Dr. Matthew Gubens is a thoracic oncologist who cares for patients with lung cancer. He specializes particularly in treating non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. In his research, Gubens studies new treatment strategies for lung cancer and other malignancies of the chest area. Gubens earned his medical degree at Stanford University School of Medicine. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Stanford. He also earned a master's degree in health policy and management at the Harvard T.H. Chan School of Public Health. Gubens is a member of the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and International Thymic Malignancy Interest Group. Dr. Gubens is rated as a Distinguished provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Lung Adenocarcinoma. Dr. Gubens is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gubens is currently accepting new patients.

Dr. Arpita Desai is a medical oncologist who specializes in caring for patients with genitourinary cancers (cancers of the genital or urinary organs). She particularly focuses on kidney and prostate cancers. She serves as medical director of the genitourinary medical oncology program at UCSF, where she leads efforts to deliver multidisciplinary, patient-centered care and advance innovative treatments. She also leads the UCSF kidney cancer program, which brings together clinical care, translational research and innovation to improve outcomes for patients with renal cell carcinoma. She also serves as medical director of the UCSF Von Hippel–Lindau multidisciplinary clinic, which integrates oncology, genetics, nephrology, ophthalmology, neurosurgery, endocrinology and other specialties to provide comprehensive, coordinated care for patients with Von-Hippel Lindau disease (a rare genetic disorder that increases a patient's risk of tumors). Through her leadership, research and national collaborations, Desai is committed to advancing precision medicine in kidney cancer and improving the lives of patients through both cutting-edge clinical care and translational research (lab findings that can lead to improvements in real-world patient care). In research, Desai is interested in developing novel imaging and treatment strategies for renal cell carcinoma, the most common type of kidney cancer. She is particularly interested in integrating functional and molecular imaging to personalize treatment and improve patient outcomes. Her research program examines theranostics, hyperpolarized MRI and biomarker-driven approaches to optimize treatments for genitourinary cancers. Desai earned her medical degree at Rajiv Gandhi University of Health Sciences in India. She completed a residency in internal medicine at the State University of New York at Buffalo, where she served as chief resident. She completed a fellowship in medical oncology at the University of Chicago. Desai is an active member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research and the National Comprehensive Cancer Network (NCCN) Kidney Cancer Guidelines Panel. She has received a Cancer Research Institute Investigator’s Technology Impact Award, Conquer Cancer Foundation of ASCO Merit Award and Dexter S. Levy, MD, Memorial Award for her commitment to teaching and excellence in patient care and has also been recognized with several awards for her mentorship and research. Dr. Desai is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Clear Cell Sarcoma, and Wilms Tumor. Dr. Desai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Desai is currently accepting new patients.

Dr. David Oh is a medical oncologist who cares for patients who are receiving novel immunotherapies for cancers as part of clinical trials. These are treatments that harness the patient's own immune system to fight cancer. He specializes in prostate and bladder cancers. Oh's research focuses on understanding and improving cancer immunotherapies. He leads clinical trials to evaluate new immunotherapies for solid tumors, and he studies samples from patients who have received immunotherapies with the goal of better understanding their benefits and side effects. Oh earned his medical degree from Stanford University School of Medicine, where he also completed a doctorate in physiology. At UCSF, he completed a residency in internal medicine and a fellowship in hematology and oncology. Oh is a member of the American Society of Clinical Oncology, American Association for Cancer Research and Society for Immunotherapy of Cancer. He has received Young Investigator Awards from the Prostate Cancer Foundation, Bladder Cancer Advocacy Network and Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Oh is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Colonoscopy, and Nephrectomy. Dr. Oh is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Oh is currently accepting new patients.

Dr. Alexander Gottschalk, an expert in radiation treatment, specializes in caring for patients with lung cancer, prostate cancer and sarcoma. He directs UCSF's program in CyberKnife surgery, in which a flexible robotic arm is used to precisely deliver high doses of radiation. He uses CyberKnife and other forms of stereotactic body radiation therapy to treat cancers of the lung or prostate, as well as cancer that has spread to the bones or lymph nodes. Gottschalk earned both his medical degree and doctorate in pathology at the University of Chicago. He completed a residency in radiation oncology at UCSF. Gottschalk has received numerous awards and research grants, including a research service award and a medical scientist fellowship from the National Institutes of Health, a clinical research grant from the UCSF Helen Diller Family Comprehensive Cancer Center, a scholar award from the Radiological Society of North America and a junior faculty award from the American Society for Radiation Oncology. Dr. Gottschalk is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Pleuropulmonary Blastoma, Lung Cancer, Familial Prostate Cancer, and Prostatectomy. Dr. Gottschalk is board certified in American Board Of Radiology, Radiation Oncology. Dr. Gottschalk is currently accepting new patients.

Dr. Michael L. Cheng is a medical oncologist who cares for patients with lung cancer and other tumors affecting the chest, with a particular focus on non-small cell lung cancer. He strives to provide individualized, compassionate care through precision oncology (using the genetic profile of the patient's cancer to custom-tailor treatment). Cheng leads research centered on developing innovative, next-generation treatments for lung cancer, including therapeutic clinical trials with new targeted therapies and immunotherapies. He is inspired by how research discoveries can lead to tangible benefits for patients. Cheng earned his medical degree from the David Geffen School of Medicine at UCLA. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center. Before joining the UCSF faculty, he served as an assistant professor at the Dana-Farber Cancer Institute and Harvard Medical School. Cheng is a member of the American Society of Clinical Oncology (ASCO) and International Association for the Study of Lung Cancer. He has received the Career Development Award from Conquer Cancer, the ASCO Foundation, as well as research funding from the National Institutes of Health and National Cancer Institute. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Cheng is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Cheng is currently accepting new patients.